US prescriptions for Novo Nordisk's (NOVOB DC) Wegovy pill were 26,109 for week ended Jan 23, IQVIA data shows
The increase in prescriptions for Novo Nordisk's Wegovy pill suggests positive momentum for the company, likely reflecting strong demand for obesity treatments.
CHMP adopts positive opinion for the marketing authorization of Bayer's (BAYN GY) Finerenone for patients with heart failure with left ventricular ejection fraction ≥40%
Top Iranian security official says Iran to list armed forces of EU countries that blacklisted revolutionary guards as 'Terrorist'
US prescriptions for Novo Nordisk's (NOVOB DC) Wegovy pill were 26,109 for week ended Jan 23, IQVIA data shows
Iranian Foreign Minister regarding US threats, says outcome of negotiations cannot be dictated before the talks and nuclear programme will not be part of talks; will not negotiate its defence capabilities
Russian foreign ministry says Russia will use all the available means to defend vessels under Russian flags in case their rights are violated
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
This uptick may impact revenue forecasts and could lead to favorable analyst upgrades, indicating that the market sentiment around NOVOB.DC could shift more positively if this trend persists, particularly within the health and pharmaceuticals sector.
Related headlines
- Novo Nordisk (NOVOB DC) announced first results from the STEP Young phase 3 trial; The trial met its primary endpoint, demonstrating superior body mass index reduction at week 686 days ago
- Stellantis (STLAM IM/STLAP FP) plans to invest EUR 1bln+ to design and build a new van in France2 days ago
- Ipsen (IPN FP) CEO says that they are considering potential US manufacturing investment for plant to make neuroscience drugs2 days ago
- European Movers: Alstom (ALO FP) +1.7%, Airbus (AIR FP) +1.6%, UniCredit (UCG IM) +1%, Commerzbank (CBK GY) +0.6%, SAP (SAP GY) -1.6%2 days ago
- Additional European Equity News - 11th September 20262 days ago
- European Equity pre-Market Summary - 11th September 2026: European bourses rebound, with focus on the US CPI2 days ago
- Newsquawk Daily European Equity Opening News - 11th September 20262 days ago
- Ryanair (RYA ID) CEO says that if oil prices remain higher into the next year, then he believes that there will be a "significant" uplift in airfares; have stopped hedging oil prices in recent weeks3 days ago
- European Movers: Fortum (FORTUM FH) +3%, Porsche AG (P911 GY) +1.4%, Novartis (NOVN SW) +0.8%, Associated British Foods (ABF LN) -10%3 days ago
- Additional European Equity News - 10th September 20263 days ago
- European Equity pre-Market Summary - 10th September 2026: European bourses set for a mildly firmer open; Porsche AG lifts guidance3 days ago
- Newsquawk Daily European Equity Opening News - 10th September 20263 days ago
- Crystler (STLAM IM/STLAP FP) files to recall over 200k US vehicles4 days ago
- European Movers: Airbus (AIR FP) -1.3%, LVMH (MC FP) -1.3%, Orsted (ORSTED DC) -1.6%, Inditex (ITX SM) -3%, Burberry (BRBY LN) -3%4 days ago
- Additional European Equity News - 9th September 20264 days ago
- European Equity pre-Market Summary - 9th September 2026: European bourses are indicative of a slightly softer open; Inditex reports poor results4 days ago
- Newsquawk Daily European Equity Opening News - 9th September 20264 days ago
- European Movers: Airbus (AIR FP) -0.7%, Schneider Electric (SU FP) -0.9%, Société Générale (GLE FP) -1.6%, Infineon (IFX GY) -1.9%, Novartis (NOVN SW) -9%, 5 days ago
- Additional European Equity News - 8th September 20265 days ago
- European Equity pre-Market Summary - 8th September 2026: Novartis does not meet Phase 3 primary endpoint; European equity futures indicative of a slightly lower open, as energy picks up5 days ago
The whole workspace, free to try.
Try it free